X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

International Law Enforcement Action Against Fake Medicines

Yuvraj_pawp by Yuvraj_pawp
2nd September 2014
in Europe, Facilities & Operation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Law enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and the United Kingdom, supported by Europol and Eurojust, today contributed to simultaneous operations to stop the distribution of prescription-only counterfeit medicines in the European Union.

Today’s operations resulted in seizures of several million pills with an estimated value well in excess of EUR 10 million, a large amount of cash and several vehicles, including luxury models, and the freezing of more than EUR 7.5 million in bank accounts and assets. In addition, 12 suspects were arrested.

The law enforcement activities aimed to specifically counter the activities of the organised crime group (OCG) behind the supply and online distribution of counterfeit medicines – mainly erectile dysfunction pills – and their money laundering activities.

Following intelligence gathered during a criminal pharma case by the authorities in Spain that provided Europol with useful leads and that also assisted further investigations in Austria, France and the UK, several operational meetings were held to inform and exchange information with the concerned Member States and other involved countries. Eurojust organised a coordination meeting to discuss a common strategy among the authorities involved, including the establishment of a joint investigation team (JIT) among Spain, Austria, France and the UK and supported by the authorities in Cyprus, Hungary, and Slovakia, and common action days. Members of the JIT will now travel to other involved countries to facilitate the exchange of information.

Since the beginning of the investigation in September 2012, more than 300 000 pills with an estimated value of EUR 2 million have been seized in Austria alone. However, it is thought that this represents only one-fifth of the total transactions made by the OCG in Austria. In France, payments totalling EUR 9 million were identified as having been processed over three years. In Spain, counterfeit goods worth more than EUR 1.5 million have been seized and three people arrested. Over the last two years, the UK authorities have identified more than EUR 12 million in transactions involving counterfeit and unlicensed medicines. The Hungarian authorities were involved in a similar operation last year.

These latest operations were coordinated from Eurojust premises in The Hague. This facilitated the swift exchange of information, resolution of legal issues and the elaboration of a final overview of the results, tailor-made for the needs of the involved judicial authorities. At the same time, Europol provided valuable assistance by deploying a mobile office for real-time analysis and cross-checking of data on the spot. Simultaneously, experts and analysts from Europol assisted the police and provided forensic and analytical support during the action day.

The counterfeit medicines targeted by this operation are imported into the European Union from Asia and contain incorrect dosages and ingredients which pose a serious health hazard.

Previous Post

Senesco completes patient enrolment in Phase Ib/IIa SNS01-T trial

Next Post

Gilenya® data at ACTRIMS-ECTRIMS to show Novartis is redefining MS treatment goals for patients

Related Posts

API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
API Manufacturing Facility
Americas

Lilly to Build $6.5B API Manufacturing Facility in Houston

25th September 2025
Merck and Siemens
Drug Development

Merck and Siemens to Accelerate AI Driven Drug Development

24th September 2025
Scottish Pharma Sector
Europe

ABPI Launches Manifesto to Advance Scottish Pharma Sector

23rd September 2025
Automating Experimental Design with Generative AI in Pharma
Facilities & Operation

Automating Experimental Design with Generative AI in Pharma

20th September 2025
Next Post

ABBOTT RECEIVES CE MARK FOR FREESTYLE® LIBRE, A REVOLUTIONARY GLUCOSE MONITORING SYSTEM FOR PEOPLE WITH DIABETES

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In